Latest Podcasts

Apocalyptic Scenarios and Infectious Disease

By Carlos Lopez-Perez, MD

July 8th, 2019

Dr. Lopez-Perez examines the infectious diseases syndromes that via bioterrorism and natural outbreaks could be responsible for “end of the world” scenarios. He initially focuses on agents of bioterrorism, including Anthrax, Smallpox, Plague, Tularemia and Botulism. He then goes on to discuss the threat posed by pandemic influenza. He also touches upon the possibility of genetically engineered pandemics, in which techniques such as “CRISPR” could be used to create “designer organisms” or to replicate or modify already fearsome pathogens (such as influenza or smallpox) with devastating results.

CAR-T Therapy: A Burgeoning New Cancer Treatment

By Natan Kraitman, MD

May 24th, 2019

Dr. Kraitman reviews the chronology of cancer treatment history, beginning with the dawn of cancer surgery and progressing through radiation, chemotherapy, immunotherapy, and ultimately, gene therapy. He then explains the basics of Chimeric Antigen Recepter T Cell therapy, a new state of the art therapy utilizing targeted T cells to destroy specific cancer cells. Dr. Kraitman then discusses potential toxicities of CART therapy, including neurotoxicty, Cytokine release syndrome, and HLH, and approaches to manage these adverse effects. Lastly, the speaker discusses infections associated with CAR-T therapy, including bacterial, fungal, and viral pathogens from a clinical series.

Tickborne Diseases: A Rising Concern

By Vidhya Sabapathy, MD

May 17th, 2019

Dr. Sabapathy reviews the epidemiology of tick-borne diseases. She discusses the common identification techniques for the various tick species. She compares and contrasts Lyme disease versus Southern Tick-associated Rash Illness (STARI). She also draws a distinction between Lyme and Borrellia myamotoi. Lastly, she discusses how climate change is increasing the prevalence and distribution of tick-associated infectious diseases.

Got Breast Milk?

By Johonna Asquith, MD

May 10th, 2019

In this comprehensive review of breast feeding and breast milk by a physician and new mom, Dr. Asquith opens by discussing why breast feeding benefits both babies and their mothers. She relates the common reasons why some moms elect not to breast feed or stop breast feeding early. Dr. Asquith then shares data on the epidemiology of breast feeding by across the country. Next, she mentions the typical schedule for a breast feeding mom and essential care steps to ensure proper hygiene for breast feeding equipment. Dr. Asquith then dives deeper into some of the immunological and anti-infective benefits of nursing. She then shares information on the safety of nursing when a mom is sick with infectious syndromes like the Flu, travelers diarrhea, HSV and Zika virus. She closes by touching on milk banking and human milk pasteurization.

Infections Associated with Biologic Therapies

By Olga Klinkova, MD

April 23rd, 2019

Dr. Klinkova reviews the general types of biologic agents available for patients today and their classification system. She focuses specifically on Tumor Necrosis Factor alpha (TNF-alpha) inhibitors. Dr. Klinkova extensively reviews their noninfectious and infectious adverse effects. Among the infectious complications, mycobacterial disease is among the most significant, and she reviews risk factors, screening, and prevention. Lastly, Dr. Klinkova reviews bacterial and viral complications of TNF agents, and closes by mentioning anti-integrin and anti-IL 12/23 agents.

Exposures Associated with Large Animal Bites

By Christina Garcia, MD

April 16th, 2019

Dr. Garcia takes a close look at how large animal bites of can cause significant morbidity to human victims. She first reviews exposures due to large cats, including lions and tigers. She then discusses bites due to bears. Next, she discusses exposures due to reptiles, including venomous snakes. She emphasizes the knowledge and tools that infectious diseases specialists and patients need to know to prevent exposures and to treat them after they occur.

Pro-Cons-itonin: The Advantages and Disadvantages of Procalcitonin-based Therapy

By Sidorela Gllava

April 5th, 2019

Dr. Gllava reviews the value of the procalcitonin laboratory test as an inflammatory marker useful in making treatment decisions in infectious diseases patients. First, she introduces the idea of a biomarker: a laboratory assay that is useful in detecting inflammatory states. She then explains the advantages and disadvantages of procalcitonin as an ideal biomarker. Dr. Gllava goes on to describe the current recommendations for the use of procalcitonin in specific infectious conditions and reviews the body of scientific evidence for its use. Lastly, she reviews how hospitals can utilize procalcitonin-based algorithms to improve clinical care and promote antimicrobial stewardship.

A Brief History of HIV: Then and Now

By Shylah Moore-Pardo, MD

February 27th, 2019

Dr. Moore Pardo’s comprehensive timeline of HIV and AIDS spans the last 40 years of the history of HIV infection. She covers the important decade of the 1980’s, when the epidemic was first recognized, the virus identified, and public awareness of the syndrome was heightened by the deaths of celebrities such as Rock Hudson. She then discusses drug development and the age of HAART in the 1990s. The decade of the 2000s focused upon access to care and curbing the epidemic on an international scale with programs like PEPFAR and private philanthropy initiatives. She closes by looking at where we are in the HIV epidemic over the last decade as the medical community begins to discuss a possible end to new cases of HIV in the US by 2030.